Understanding autoimmune uveitis through animal models. The Friedenwald Lecture.
作者信息
Caspi Rachel R
机构信息
National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892-1857, USA.
出版信息
Invest Ophthalmol Vis Sci. 2011 Mar 30;52(3):1872-9. doi: 10.1167/iovs.10-6909. Print 2011 Mar.
Abstract
摘要
相似文献
1
Understanding autoimmune uveitis through animal models. The Friedenwald Lecture.
Invest Ophthalmol Vis Sci. 2011 Mar 30;52(3):1872-9. doi: 10.1167/iovs.10-6909. Print 2011 Mar.
2
Why HLA-B27? My thirty-year quest: the Friedenwald lecture.
Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7712-5, 7711. doi: 10.1167/iovs.11-8247.
3
Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications.
Invest Ophthalmol Vis Sci. 1991 Dec;32(13):3131-41.
4
Proctor Lecture. Experimental allergic uveitis. Investigations of retinal autoimmunity and the immunopathologic responses evoked.
Invest Ophthalmol Vis Sci. 1991 Dec;32(13):3119-28.
5
The Eye Sees Eye to Eye With the Immune System: The 2019 Proctor Lecture.
Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4489-4495. doi: 10.1167/iovs.19-28632.
6
Roles of interleukin-17 in uveitis.
Indian J Ophthalmol. 2016 Sep;64(9):628-634. doi: 10.4103/0301-4738.194339.
7
Friedenwald Award and Lecture. Introduction of R. F. Brubaker, Friedenwald Award winner 1991.
Invest Ophthalmol Vis Sci. 1991 Dec;32(13):3142-3; discussion 3144.
8
Introducing Samuel M. Wu, the 2009 Recipient of the Friedenwald Award.
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1263. doi: 10.1167/iovs.09-4480.
9
The double-edged ocular immune response: the Cogan lecture.
Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3243-8.
10
Introducing Ilene K. Gipson, the 2007 recipient of the Friedenwald award.
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4390. doi: 10.1167/iovs.07-0757.
引用本文的文献
1
Comparative Efficacy of Interleukin-7 and -15 Blockade in Alleviating Experimental Chronic Uveitis and Suppressing Pathogenic Memory CD4+ T Cells.
Invest Ophthalmol Vis Sci. 2025 May 1;66(5):9. doi: 10.1167/iovs.66.5.9.
2
Kinetic changes in microglia-related retinal transcripts in experimental autoimmune uveoretinitis (EAU) of B10.RIII mice.
J Neuroinflammation. 2025 Feb 10;22(1):37. doi: 10.1186/s12974-025-03358-x.
3
Association between iridocyclitis and immune-related disease: A 2-sample Mendelian randomization study.
Medicine (Baltimore). 2024 Nov 29;103(48):e40663. doi: 10.1097/MD.0000000000040663.
4
Crystallin β-b2 promotes retinal ganglion cell protection in experimental autoimmune uveoretinitis.
Front Cell Neurosci. 2024 Sep 10;18:1379540. doi: 10.3389/fncel.2024.1379540. eCollection 2024.
5
High salt diet alleviates disease severity in native experimental autoimmune uveitis.
Front Ophthalmol (Lausanne). 2024 May 31;4:1370374. doi: 10.3389/fopht.2024.1370374. eCollection 2024.
6
Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non-infectious uveitis.
Clin Transl Immunology. 2023 Dec 12;12(12):e1479. doi: 10.1002/cti2.1479. eCollection 2023.
7
Local Myeloid-Derived Suppressor Cells Impair Progression of Experimental Autoimmune Uveitis by Alleviating Oxidative Stress and Inflammation.
Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):39. doi: 10.1167/iovs.64.13.39.
8
Immunology of Retinitis Pigmentosa and Gene Therapy-Associated Uveitis.
Cold Spring Harb Perspect Med. 2024 Jan 2;14(1):a041305. doi: 10.1101/cshperspect.a041305.
9
Long-lived autoreactive memory CD4 T cells mediate the sustained retinopathy in chronic autoimmune uveitis.
FASEB J. 2023 Apr;37(4):e22855. doi: 10.1096/fj.202202164R.
10
Comprehensive LncRNA and Potential Molecular Mechanism Analysis in Noninfectious Uveitis.
Transl Vis Sci Technol. 2023 Mar 1;12(3):2. doi: 10.1167/tvst.12.3.2.
本文引用的文献
1
A look at autoimmunity and inflammation in the eye.
J Clin Invest. 2010 Sep;120(9):3073-83. doi: 10.1172/JCI42440. Epub 2010 Sep 1.
2
Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation.
Scand J Immunol. 2010 Sep;72(3):173-84. doi: 10.1111/j.1365-3083.2010.02432.x.
3
Th1 and Th17 cells: adversaries and collaborators.
Ann N Y Acad Sci. 2010 Jan;1183:211-21. doi: 10.1111/j.1749-6632.2009.05133.x.
4
Role of ocular pigment epithelial cells in immune privilege.
Arch Immunol Ther Exp (Warsz). 2009 Jul-Aug;57(4):263-8. doi: 10.1007/s00005-009-0030-0. Epub 2009 Jul 1.
5
Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.
J Immunol. 2008 Oct 1;181(7):4791-7. doi: 10.4049/jimmunol.181.7.4791.
6
Common genetic determinants of uveitis shared with other autoimmune disorders.
J Immunol. 2008 May 15;180(10):6751-9. doi: 10.4049/jimmunol.180.10.6751.
7
Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.
Invest Ophthalmol Vis Sci. 2008 May;49(5):1946-56. doi: 10.1167/iovs.07-0868.
8
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.
J Exp Med. 2008 Apr 14;205(4):799-810. doi: 10.1084/jem.20071258. Epub 2008 Apr 7.
9
Differentially expressed genes in MHC-compatible rat strains that are susceptible or resistant to experimental autoimmune uveitis.
Invest Ophthalmol Vis Sci. 2008 May;49(5):1957-70. doi: 10.1167/iovs.07-1295. Epub 2008 Feb 15.
10
Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells.
J Immunol. 2007 Oct 15;179(8):5146-58. doi: 10.4049/jimmunol.179.8.5146.
Zotero 插件